$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000163883324000029 Filed on February 26, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$717.4M	$735.4M	$2.743B
YoY Change	7.69%	4.0%	8.03%
Cost Of Revenue	$540.7M	$521.2M	$2.011B
YoY Change	5.85%	3.78%	6.85%
Gross Profit	$176.7M	$214.2M	$732.4M
YoY Change	13.71%	4.54%	11.43%
Gross Profit Margin	24.63%	29.13%	26.7%
Selling, General & Admin	$54.60M	$41.50M	$205.8M
YoY Change	2.25%	-15.82%	11.48%
% of Gross Profit	30.9%	19.37%	28.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$33.70M	$31.10M	$118.1M
YoY Change	0.0%	5.07%	2.87%
% of Gross Profit	19.07%	14.52%	16.13%
Operating Expenses	$641.4M	$68.30M	$2.415B
YoY Change	3.48%	-2.01%	10.08%
Operating Profit	$76.00M	$145.9M	$328.0M
YoY Change	63.79%	7.91%	-4.98%
Interest Expense	-$47.30M	-$43.90M	-$193.0M
YoY Change	1.07%	-22.44%	-17.84%
% of Operating Profit	-62.24%	-30.09%	-58.84%
Other Income/Expense, Net	$400.0K		$8.600M
YoY Change			473.33%
Pretax Income	$28.70M	$52.70M	$135.0M
YoY Change	-7275.0%	58.73%	22.39%
Income Tax	$4.400M	$6.000M	-$300.0K
% Of Pretax Income	15.33%	11.39%	-0.22%
Net Earnings	-$12.40M	-$1.000M	-$11.90M
YoY Change	-50.2%	-95.73%	-78.21%
Net Earnings / Revenue	-1.73%	-0.14%	-0.43%
Basic Earnings Per Share	-$0.10		-$0.09
Diluted Earnings Per Share	-$0.10	-$0.01	-$0.09
COMMON SHARES
Basic Shares Outstanding	126.6M shares	126.5M shares	125.6M shares
Diluted Shares Outstanding	126.0M shares		125.6M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$185.2M	$195.9M	$195.9M
YoY Change	-24.56%	-30.75%	-30.75%
Cash & Equivalents	$185.2M	$195.9M	$195.9M
Short-Term Investments
Other Short-Term Assets	$107.7M	$96.50M	$127.5M
YoY Change	55.19%	22.15%	15.49%
Inventory	$77.00M	$75.20M	$75.20M
Prepaid Expenses	$31.70M	$31.00M
Receivables	$494.3M	$496.4M	$496.4M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$895.9M	$895.0M	$895.0M
YoY Change	3.11%	-2.82%	-2.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.241B	$1.224B	$1.224B
YoY Change	10.93%	5.91%	5.91%
Goodwill	$4.398B	$4.326B
YoY Change	4.27%	4.57%
Intangibles		$54.80M
YoY Change		29.55%
Long-Term Investments	$188.7M	$184.1M	$184.1M
YoY Change	-1.51%	-3.26%	-3.26%
Other Assets	$112.4M	$103.3M	$192.8M
YoY Change	-5.23%	-28.36%	-18.2%
Total Long-Term Assets	$6.080B	$5.982B	$5.982B
YoY Change	5.29%	3.83%	3.83%
TOTAL ASSETS
Total Short-Term Assets	$895.9M	$895.0M	$895.0M
Total Long-Term Assets	$6.080B	$5.982B	$5.982B
Total Assets	$6.976B	$6.877B	$6.877B
YoY Change	5.0%	2.91%	2.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$174.1M	$171.8M	$171.8M
YoY Change	20.57%	13.32%	13.32%
Accrued Expenses	$222.3M	$219.9M	$219.9M
YoY Change	13.3%	15.55%	15.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$77.20M	$73.30M	$73.30M
YoY Change	22.73%	16.72%	16.72%
Total Short-Term Liabilities	$523.4M	$523.0M	$523.0M
YoY Change	10.17%	6.0%	6.0%
LONG-TERM LIABILITIES
Long-Term Debt	$2.794B	$2.702B	$2.702B
YoY Change	10.39%	5.58%	5.58%
Other Long-Term Liabilities	$46.30M	$41.10M	$290.0M
YoY Change	-42.27%	-45.49%	-16.38%
Total Long-Term Liabilities	$46.30M	$41.10M	$2.992B
YoY Change	-42.27%	-45.49%	2.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$523.4M	$523.0M	$523.0M
Total Long-Term Liabilities	$46.30M	$41.10M	$2.992B
Total Liabilities	$569.7M	$564.1M	$4.890B
YoY Change	2.59%	-0.83%	4.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$581.6M	-$569.2M
YoY Change	-0.12%	2.14%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.967B	$1.987B	$1.987B
YoY Change
Total Liabilities & Shareholders Equity	$6.976B	$6.877B	$6.877B
YoY Change	5.0%	2.91%	2.91%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$12.40M	-$1.000M	-$11.90M
YoY Change	-50.2%	-95.73%	-78.21%
Depreciation, Depletion And Amortization	$33.70M	$31.10M	$118.1M
YoY Change	0.0%	5.07%	2.87%
Cash From Operating Activities	$40.70M	$62.60M	$293.8M
YoY Change	-45.37%	769.44%	85.01%
INVESTING ACTIVITIES
Capital Expenditures	$21.00M	$19.80M	$88.80M
YoY Change	-13.58%	-12.78%	10.17%
Acquisitions	$54.60M		$80.00M
YoY Change	34.15%		-45.36%
Other Investing Activities	$7.000M	-$38.30M	$33.70M
YoY Change	70.73%	-22.63%	193.04%
Cash From Investing Activities	-$83.10M	-$58.10M	-$225.6M
YoY Change	17.54%	-19.53%	-26.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$120.2M		$807.1M
YoY Change	655.97%		-6.37%
Cash From Financing Activities	$31.70M	-44.60M	-$155.2M
YoY Change	-176.94%	-123.1%	-468.65%
NET CHANGE
Cash From Operating Activities	$40.70M	62.60M	$293.8M
Cash From Investing Activities	-$83.10M	-58.10M	-$225.6M
Cash From Financing Activities	$31.70M	-44.60M	-$155.2M
Net Change In Cash	-$10.70M	-40.10M	-$87.00M
YoY Change	-71.39%	-131.3%	-18.69%
FREE CASH FLOW
Cash From Operating Activities	$40.70M	$62.60M	$293.8M
Capital Expenditures	$21.00M	$19.80M	$88.80M
Free Cash Flow	$19.70M	$42.80M	$205.0M
YoY Change	-60.76%	-376.13%	162.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	158800000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	87100000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	88800000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	80600000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	80000000.0	usd
CY2023	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-14400000	usd
CY2022	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-11100000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	14200000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11300000	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-10600000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	29300000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001638833
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList	http://www.surgerypartners.com/20231231#GainLossOnDispositionOfAssetsAndDeconsolidation
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023	us-gaap	Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#InterestIncomeExpenseNonoperatingNet
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-37576
CY2023	dei	Entity Registrant Name EntityRegistrantName	Surgery Partners, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3620923
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	340 Seven Springs Way, Suite 600
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Brentwood
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37027
CY2023	dei	City Area Code CityAreaCode	615
CY2023	dei	Local Phone Number LocalPhoneNumber	234-5900
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	SGRY
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	4700000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126607086	shares
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Location AuditorLocation	Nashville, Tennessee
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	195900000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	282900000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	496400000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	456300000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	75200000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	71400000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	31000000.0	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	31400000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	96500000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	79000000.0	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	895000000.0	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	921000000.0	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	968700000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	876600000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54800000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4326000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4137100000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	184100000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	190300000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	255300000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	279100000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	89500000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	91500000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	103300000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	144200000	usd
CY2023Q4	us-gaap	Assets Assets	6876700000	usd
CY2022Q4	us-gaap	Assets Assets	6682100000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	171800000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	151600000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	73800000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	68900000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	204100000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	210100000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	73300000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	62800000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	523000000.0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	493400000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2701800000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2559000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	248900000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	271400000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41100000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	75400000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	327400000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	342000000.0	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20310000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20310000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126593727	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126593727	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	125960834	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	125960834	shares
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1300000	usd
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1300000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2497600000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2478000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	57500000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	76200000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-569200000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-557300000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1987200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1998200000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1047300000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	942700000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3034500000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2940900000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6876700000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6682100000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2743300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2539300000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2225100000	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	793800000	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	746400000	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	644300000	usd
CY2023	us-gaap	Supplies Expense SuppliesExpense	745000000.0	usd
CY2022	us-gaap	Supplies Expense SuppliesExpense	709700000	usd
CY2021	us-gaap	Supplies Expense SuppliesExpense	636400000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	296800000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	269200000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	230000000.0	usd
CY2023	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	84900000	usd
CY2022	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	82400000	usd
CY2021	sgry	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	90600000	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	175300000	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	156700000	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	132400000	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2095800000	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1964400000	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1733700000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	120900000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	102200000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	104000000.0	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118100000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	114800000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98800000	usd
CY2023	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	61700000	usd
CY2022	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	47500000	usd
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	39800000	usd
CY2023	sgry	Grant Revenue GrantRevenue	1100000	usd
CY2022	sgry	Grant Revenue GrantRevenue	2400000	usd
CY2021	sgry	Grant Revenue GrantRevenue	37900000	usd
CY2021	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-2200000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12500000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14900000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9100000	usd
CY2021	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-15500000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-193000000.0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	135000000.0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	110300000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23300000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10500000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	135300000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	87000000.0	usd
CY2021	us-gaap	Profit Loss ProfitLoss	70700000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	147200000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	141600000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	141600000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11900000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-54600000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70900000	usd
CY2023	sgry	Undistributed Earnings Loss Allocatedto Participating Securities Including Dividends Accrued UndistributedEarningsLossAllocatedtoParticipatingSecuritiesIncludingDividendsAccrued	0	usd
CY2022	sgry	Undistributed Earnings Loss Allocatedto Participating Securities Including Dividends Accrued UndistributedEarningsLossAllocatedtoParticipatingSecuritiesIncludingDividendsAccrued	0	usd
CY2021	sgry	Undistributed Earnings Loss Allocatedto Participating Securities Including Dividends Accrued UndistributedEarningsLossAllocatedtoParticipatingSecuritiesIncludingDividendsAccrued	10300000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11900000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11900000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-54600000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-54600000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-81200000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-81200000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125613000	shares
CY2023	us-gaap	Profit Loss ProfitLoss	135300000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	87000000.0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-18700000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	107700000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	29500000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	116600000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	194700000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	100200000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	147200000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	141600000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	141600000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30600000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	53100000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41400000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	882100000	usd
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	21800000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9000000.0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	10300000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	439700000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	554200000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	29500000	usd
CY2021	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	131200000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	87600000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1969600000	usd
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	42500000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22500000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	857700000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	107700000	usd
CY2022	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	44600000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	103700000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2940900000	usd
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	97500000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18500000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18700000	usd
CY2023	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	99300000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	103000000.0	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3034500000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	135300000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	87000000.0	usd
CY2021	us-gaap	Profit Loss ProfitLoss	70700000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118100000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	114800000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98800000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	35200000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	34800000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	39100000	usd
CY2023	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-25000000.0	usd
CY2022	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-25900000	usd
CY2021	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-22000000.0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	17700000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18400000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	17400000	usd
CY2023	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-14400000	usd
CY2022	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-11100000	usd
CY2021	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-2200000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-15500000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14900000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9100000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1700000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21900000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8900000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	2200000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	1800000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-200000	usd
CY2023	us-gaap	Other Noncash Income OtherNoncashIncome	0	usd
CY2022	us-gaap	Other Noncash Income OtherNoncashIncome	7500000	usd
CY2021	us-gaap	Other Noncash Income OtherNoncashIncome	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	47200000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35300000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32100000	usd
CY2023	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	-1200000	usd
CY2022	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	-58400000	usd
CY2021	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	-73600000	usd
CY2023	sgry	Increase Decrease In Settlement Payments IncreaseDecreaseInSettlementPayments	0	usd
CY2022	sgry	Increase Decrease In Settlement Payments IncreaseDecreaseInSettlementPayments	0	usd
CY2021	sgry	Increase Decrease In Settlement Payments IncreaseDecreaseInSettlementPayments	32200000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	15100000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	67000000.0	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	43400000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	293800000	usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6000000.0	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	95100000	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	1400000	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	12800000	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	5400000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	33700000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	11500000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-300000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-225600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-307900000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-331700000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	807100000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	862000000.0	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	343200000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	826600000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	217800000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	299400000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	24300000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11700000	usd
CY2023	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	usd
CY2022	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	11300000	usd
CY2021	sgry	Debt Instrument Prepayment Penalty Amount DebtInstrumentPrepaymentPenaltyAmount	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	882900000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	581800000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	25200000	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	27600000	usd
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	146100000	usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	146800000	usd
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	131000000.0	usd
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	8200000	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-3400000	usd
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-28400000	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5100000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-12500000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-9900000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-17900000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-155200000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42100000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	316300000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-87000000.0	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-107000000.0	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	71700000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	282900000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	389900000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	318200000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	195900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	282900000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	389900000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	169600000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	218700000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	194300000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1400000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1800000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1500000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	18000000.0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	29900000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	22300000	usd
CY2023Q4	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	162	facility
CY2023Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	33	state
CY2023Q4	sgry	Number Of Surgical Facilities Owned Majority Interest NumberOfSurgicalFacilitiesOwnedMajorityInterest	90	facility
CY2023Q4	sgry	Number Of Surgical Facilities Owned Consolidated NumberOfSurgicalFacilitiesOwnedConsolidated	123	facility
CY2022	sgry	Number Of Deconsolidations NumberOfDeconsolidations	2	integer
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2743300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2539300000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2225100000	usd
CY2023	sgry	Grant Revenue GrantRevenue	1100000	usd
CY2022	sgry	Grant Revenue GrantRevenue	2400000	usd
CY2021	sgry	Grant Revenue GrantRevenue	37900000	usd
CY2022Q4	sgry	Unrecognized Grant Funds Received UnrecognizedGrantFundsReceived	3000000	usd
CY2022	sgry	Coronavirus Aid Relief And Economic Security Act Cares Act Government Grant Received Repayments CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments	60000000	usd
CY2021	sgry	Coronavirus Aid Relief And Economic Security Act Cares Act Government Grant Received Repayments CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments	60000000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	342000000.0	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	330200000	usd
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	37800000	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	44500000	usd
CY2023	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-9300000	usd
CY2022	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	10400000	usd
CY2023	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	43100000	usd
CY2022	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	43100000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	327400000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	342000000.0	usd
CY2023Q4	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	7	facility
CY2023Q4	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	5	physician_practice
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	716300000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	631300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1423100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	1250900000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	454400000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	374300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	968700000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	876600000	usd
CY2023	us-gaap	Depreciation Depreciation	112800000	usd
CY2022	us-gaap	Depreciation Depreciation	112100000	usd
CY2021	us-gaap	Depreciation Depreciation	94500000	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	reporting_unit
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4137100000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	3911800000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	225900000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	269700000	usd
CY2023	sgry	Goodwill Written Off Related To Sale Of Business Unit And Deconsolidations GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidations	37000000.0	usd
CY2022	sgry	Goodwill Written Off Related To Sale Of Business Unit And Deconsolidations GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidations	44400000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4326000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4137100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	32600000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	40200000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	52400000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	25100000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27300000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	14600000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	14600000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	15000000.0	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	15000000.0	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	87400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	32600000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54800000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	67400000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	25100000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42300000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7600000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6400000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5000000.0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	17000000.0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	40200000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	693600000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	585700000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	27100000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10200000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2775100000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2621800000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	73300000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	62800000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2701800000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2559000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	73300000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	264800000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	62600000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	376400000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	51100000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1975600000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2803800000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P10Y
CY2023	sgry	Lessee Operating Lease Option To Extend Number Of Options To Renew LesseeOperatingLeaseOptionToExtendNumberOfOptionsToRenew	1	lease_renewal_option
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	255300000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	279100000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	587000000.0	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	529600000	usd
CY2023Q4	sgry	Lease Right Of Use Asset LeaseRightOfUseAsset	842300000	usd
CY2022Q4	sgry	Lease Right Of Use Asset LeaseRightOfUseAsset	808700000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36500000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	248900000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	271400000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	286500000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	307900000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	25400000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	20900000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	668200000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	564800000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	693600000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	585700000	usd
CY2023Q4	sgry	Lease Liability LeaseLiability	980100000	usd
CY2022Q4	sgry	Lease Liability LeaseLiability	893600000	usd
CY2023	sgry	Increase Decrease In Finance Lease Liability IncreaseDecreaseInFinanceLeaseLiability	97100000	usd
CY2023	sgry	Increase Decrease In Finance Lease Right Of Use Assets IncreaseDecreaseInFinanceLeaseRightOfUseAssets	95700000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-38400000	usd
CY2023	sgry	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-36900000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M12D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P20Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M12D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P20Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.082
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.082
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.091
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.088
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	65700000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	65500000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	39900000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	38800000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	48600000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	42700000	usd
CY2023	sgry	Finance Lease Cost FinanceLeaseCost	88500000	usd
CY2022	sgry	Finance Lease Cost FinanceLeaseCost	81500000	usd
CY2023	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	20100000	usd
CY2022	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	18500000	usd
CY2023	us-gaap	Lease Cost LeaseCost	174300000	usd
CY2022	us-gaap	Lease Cost LeaseCost	165500000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	63700000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	63200000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	45800000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	41700000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	26700000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	24600000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	60100000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	57300000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	167500000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	180200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	59100000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	77200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	54600000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	75600000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	50600000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	72800000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	42600000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	69100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	33100000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	65200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	169700000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	1220600000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	409700000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1580500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	123200000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	886900000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	286500000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	693600000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1360100000	usd
CY2022Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1518200000	usd
CY2023	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-53800000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91952000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72427000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125613000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91952000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72427000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	57400000	usd
CY2023Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	17800000	usd
CY2022Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	113400000	usd
CY2022Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	40400000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	19600000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	21400000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	14000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11900000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-54600000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-70900000	usd
CY2023	sgry	Undistributed Earnings Loss Allocatedto Participating Securities Including Dividends Accrued UndistributedEarningsLossAllocatedtoParticipatingSecuritiesIncludingDividendsAccrued	0	usd
CY2022	sgry	Undistributed Earnings Loss Allocatedto Participating Securities Including Dividends Accrued UndistributedEarningsLossAllocatedtoParticipatingSecuritiesIncludingDividendsAccrued	0	usd
CY2021	sgry	Undistributed Earnings Loss Allocatedto Participating Securities Including Dividends Accrued UndistributedEarningsLossAllocatedtoParticipatingSecuritiesIncludingDividendsAccrued	10300000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11900000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11900000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-54600000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-54600000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-81200000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-81200000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125613000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	24.50
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	30.25
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	46.50
CY2017Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	46000000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1400000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1800000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1500000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1400000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1500000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1500000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1500000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	17500000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	7900000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-200000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4300000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1100000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23300000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10500000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	28400000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	23200000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	17100000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	900000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	6000000.0	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2300000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	21500000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	29100000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20900000	usd
CY2023	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	30900000	usd
CY2022	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	30200000	usd
CY2021	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	29900000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	100000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2500000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1700000	usd
CY2023	sgry	Effective Income Tax Reconciliation Divestiture Amount EffectiveIncomeTaxReconciliationDivestitureAmount	-18900000	usd
CY2022	sgry	Effective Income Tax Reconciliation Divestiture Amount EffectiveIncomeTaxReconciliationDivestitureAmount	-1400000	usd
CY2021	sgry	Effective Income Tax Reconciliation Divestiture Amount EffectiveIncomeTaxReconciliationDivestitureAmount	-2600000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1000000.0	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1000000.0	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1300000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-500000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2023	sgry	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Amount EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementAmount	0	usd
CY2022	sgry	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Amount EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementAmount	400000	usd
CY2021	sgry	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Amount EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementAmount	700000	usd
CY2023	sgry	Effective Income Tax Rate Reconciliation Adjustments To Unrealized Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToUnrealizedAttributesAmount	0	usd
CY2022	sgry	Effective Income Tax Rate Reconciliation Adjustments To Unrealized Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToUnrealizedAttributesAmount	0	usd
CY2021	sgry	Effective Income Tax Rate Reconciliation Adjustments To Unrealized Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToUnrealizedAttributesAmount	2300000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-400000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	100000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23300000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	3600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	4100000	usd
CY2023Q4	sgry	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Compensated Absencesand Incentive Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsCompensatedAbsencesandIncentiveCompensation	3000000.0	usd
CY2022Q4	sgry	Deferred Tax Assets Tax Deferred Expense Compensationand Benefits Compensated Absencesand Incentive Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationandBenefitsCompensatedAbsencesandIncentiveCompensation	3100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	143600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	146000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2900000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	0	usd
CY2023Q4	sgry	Deferred Tax Assets Tax Deferred Expense Deferred Financing Costs DeferredTaxAssetsTaxDeferredExpenseDeferredFinancingCosts	3300000	usd
CY2022Q4	sgry	Deferred Tax Assets Tax Deferred Expense Deferred Financing Costs DeferredTaxAssetsTaxDeferredExpenseDeferredFinancingCosts	5100000	usd
CY2023Q4	sgry	Deferred Tax Assets Tax Deferred Expense Interest Limitation DeferredTaxAssetsTaxDeferredExpenseInterestLimitation	162300000	usd
CY2022Q4	sgry	Deferred Tax Assets Tax Deferred Expense Interest Limitation DeferredTaxAssetsTaxDeferredExpenseInterestLimitation	137700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	4700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	10500000	usd
CY2023Q4	sgry	Deferred Tax Asset Tax Receivable Agreement DeferredTaxAssetTaxReceivableAgreement	0	usd
CY2022Q4	sgry	Deferred Tax Asset Tax Receivable Agreement DeferredTaxAssetTaxReceivableAgreement	100000	usd
CY2023Q4	sgry	Deferred Tax Assets Right Of Use DeferredTaxAssetsRightOfUse	47200000	usd
CY2022Q4	sgry	Deferred Tax Assets Right Of Use DeferredTaxAssetsRightOfUse	52500000	usd
CY2023Q4	sgry	Deferred Tax Asset Software Development Costs DeferredTaxAssetSoftwareDevelopmentCosts	1700000	usd
CY2022Q4	sgry	Deferred Tax Asset Software Development Costs DeferredTaxAssetSoftwareDevelopmentCosts	1000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	9600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	9200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	382000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	372200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	150100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	114700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	231900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	257500000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2000000.0	usd
CY2023Q4	sgry	Deferred Tax Liabilities Basis Differencesof Partnershipsand Joint Ventures DeferredTaxLiabilitiesBasisDifferencesofPartnershipsandJointVentures	84200000	usd
CY2022Q4	sgry	Deferred Tax Liabilities Basis Differencesof Partnershipsand Joint Ventures DeferredTaxLiabilitiesBasisDifferencesofPartnershipsandJointVentures	87400000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	35600000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	44400000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1300000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	15100000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	29500000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1500000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1400000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	142400000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	166000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	89500000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	91500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	150100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	114700000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	35400000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	100000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	100000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	100000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2760515	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.88
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	9155	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.28
CY2021	sgry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm	P7Y8M12D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	366500	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.42
CY2021	sgry	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm	P7Y2M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2384860	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.82
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	301998	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	13.42
CY2022	sgry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm	P6Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	134502	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.42
CY2022	sgry	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm	P6Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1948360	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.69
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	103141	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.92
CY2023	sgry	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm	P4Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1845219	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.68
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	25700000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17700000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18400000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17400000	usd
CY2023	sgry	Defined Contribution Plan Vesting Period DefinedContributionPlanVestingPeriod	P5Y
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12600000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	11100000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	9700000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36500000	usd
CY2023Q4	srt	Payables To Customers PayablesToCustomers	23900000	usd
CY2022Q4	srt	Payables To Customers PayablesToCustomers	31900000	usd
CY2023Q4	sgry	Cost Report Liabilities Current CostReportLiabilitiesCurrent	23900000	usd
CY2022Q4	sgry	Cost Report Liabilities Current CostReportLiabilitiesCurrent	23500000	usd
CY2023Q4	sgry	Acquisition Escrow Liability Current AcquisitionEscrowLiabilityCurrent	10200000	usd
CY2022Q4	sgry	Acquisition Escrow Liability Current AcquisitionEscrowLiabilityCurrent	28800000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	17800000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	19400000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	90700000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	70000000.0	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	204100000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	210100000	usd
CY2023Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	18200000	usd
CY2022Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	20800000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10200000	usd
CY2022Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	12700000	usd
CY2021Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	30700000	usd
CY2022Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	32800000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2743300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2539300000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2225100000	usd
CY2023	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	438100000	usd
CY2022	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	380200000	usd
CY2021	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	339600000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	135000000.0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	110300000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	81200000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	147200000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	141600000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	141600000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-193000000.0	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-234900000	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-221000000.0	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	118100000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	114800000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98800000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	17700000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18400000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	17400000	usd
CY2023	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	64900000	usd
CY2022	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	48600000	usd
CY2021	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	46100000	usd
CY2023	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-14400000	usd
CY2022	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-11100000	usd
CY2021	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-2200000	usd
CY2023	sgry	Gain Loss Related To Litigation Settlement And Regulatory Change Impact GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact	-17500000	usd
CY2022	sgry	Gain Loss Related To Litigation Settlement And Regulatory Change Impact GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact	24700000	usd
CY2021	sgry	Gain Loss Related To Litigation Settlement And Regulatory Change Impact GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact	-5600000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-15500000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14900000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9100000	usd
CY2023	sgry	Undesignated Derivative Activity UndesignatedDerivativeActivity	-600000	usd
CY2022	sgry	Undesignated Derivative Activity UndesignatedDerivativeActivity	8000000.0	usd
CY2021	sgry	Undesignated Derivative Activity UndesignatedDerivativeActivity	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8600000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1500000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-200000	usd
CY2023	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	438100000	usd
CY2022	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	380200000	usd
CY2021	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	339600000	usd
CY2023	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	61700000	usd
CY2022	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	47500000	usd
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	39800000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3200000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1100000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6300000	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-10600000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	29300000	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2500000	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	4600000	usd
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	5600000	usd
CY2023	sgry	Interest Expense Impact Of Change In Letter Of Protection Regulation InterestExpenseImpactOfChangeInLetterOfProtectionRegulation	4400000	usd
CY2023Q4	us-gaap	Assets Assets	6876700000	usd
CY2022Q4	us-gaap	Assets Assets	6682100000	usd
CY2023	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	88800000	usd
CY2022	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	80600000	usd
CY2021	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	57600000	usd

Files In Submission

Name	View Source	Status
0001638833-24-000029-index-headers.html	Edgar Link	pending
0001638833-24-000029-index.html	Edgar Link	pending
0001638833-24-000029.txt	Edgar Link	pending
0001638833-24-000029-xbrl.zip	Edgar Link	pending
a2023exhibit211.htm	Edgar Link	pending
a2023exhibit231.htm	Edgar Link	pending
a2023exhibit311.htm	Edgar Link	pending
a2023exhibit312.htm	Edgar Link	pending
a2023exhibit321.htm	Edgar Link	pending
a2023exhibit97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20231231.htm	Edgar Link	pending
sgry-20231231.xsd	Edgar Link	pending
sgry-20231231_g1.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
sgry-20231231_pre.xml	Edgar Link	unprocessable
sgry-20231231_def.xml	Edgar Link	unprocessable
sgry-20231231_lab.xml	Edgar Link	unprocessable
sgry-20231231_cal.xml	Edgar Link	unprocessable
sgry-20231231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2024 Q1 Form 10-K Financial Statement

#000163883324000029 Filed on February 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2024 Q1 Form 10-K Financial Statement

#000163883324000029 Filed on February 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry